FIELD: medicine, pharmaceutics.
SUBSTANCE: invention refers to biotechnology, specifically to preparations inhibiting angiogenesis, and may be used in medicine. The method involves administering an EGFL8 antagonist to a subject suffering a pathological condition associated with angiogenesis.
EFFECT: invention enables inhibiting the vascular growth in pathological, eg tumour tissues.
14 cl, 4 dwg, 2 ex
| Title | Year | Author | Number |
|---|---|---|---|
| COMPOSITIONS AND METHODS FOR REGULATION OF VESSELS DEVELOPMENT | 2005 |
|
RU2365382C2 |
| EGFL7 ANTIBODIES AND METHODS OF APPLICATION THEREOF | 2007 |
|
RU2415870C2 |
| ANGIOPOIETIC ANGIOPOIETIN-LIKE PROTEIN 4 INHIBITORS, IN COMBINATIONS AND APPLICATION | 2005 |
|
RU2392966C2 |
| ANGIOGENESIS INHIBITION | 2008 |
|
RU2471498C2 |
| METHODS OF INHIBITING OCULAR ANGIOGENESIS | 2009 |
|
RU2530583C2 |
| METHODS AND COMPOSITIONS FOR HEPSIN MODULATION OF MACROPHAGE-STIMULATING PROTEIN | 2010 |
|
RU2539772C2 |
| METHODS AND COMPOSITIONS FOR ACTIVATION MODULATION OF HEPATOCYTE GROWTH FACTOR | 2005 |
|
RU2405041C2 |
| METHOD OF TUMOUR TREATMENT IN SUBJECT | 2006 |
|
RU2404193C2 |
| NOVEL ANTIBODIES | 2008 |
|
RU2490277C2 |
| COMBINED THERAPY WITH USING ALPHA5BETA1 ANTAGONISTS | 2007 |
|
RU2465282C2 |
